David Cory | President, Chief Executive Officer
Eiger Biopharmaceuticals

David Cory, President, Chief Executive Officer, Eiger Biopharmaceuticals

David Cory is an industry veteran with over 25-years of operating experience leading teams in large pharmaceuticals, emerging stage biotechnology, and specialty pharmaceutical organizations with an established track record across multiple therapeutic areas, including over 10 new prescription product launches, management of over 20 prescription brands, and 5 successful Orphan Drug Designation programs.


World Orphan Drug Congress USA 2018 - Conference Day Two @ 14:50

Multiple clinical-staged programs for the treatment of rare diseases

back to speakers